Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice

OBJECTIVES: High fructose feeding changes fibroblast growth factor 21 (FGF21) regulation. Lactobacillus rhamnosus GG (LGG) supplementation reduces fructose-induced non-alcoholic fatty liver disease (NAFLD). The aim of this study was to determine the role of FGF21 and underlying mechanisms in the pro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Metab
Principais autores: Zhao, Cuiqing, Liu, Liming, Liu, Qi, Li, Fengyuan, Zhang, Lihua, Zhu, Fenxia, Shao, Tuo, Barve, Shirish, Chen, Yiping, Li, Xiaokun, McClain, Craig J., Feng, Wenke
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6812038/
https://ncbi.nlm.nih.gov/pubmed/31668386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2019.08.020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados